Naturally Splendid Announces CANEX Foods As Master Distributor And Initial Purchase Order

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce the appointment of Canadian-based CANEX Foods as Master Distributor for NATERA Plant Based Foods in Canada

Previously, Naturally Splendid announced CANEX Foods as a distributor of Natera Plant Based Foods. By appointing CANEX Foods as Master Distributor, Naturally Splendid benefits in a multitude of ways resulting in an overall reduction of operating costs while increasing services and margins. Benefits include increased storage capacity, daily scheduled delivery services, inventory management, as well as a working relationship with a wide selection of distributors through existing CANEX relationships including Sysco, Gordon Food Service, Intercity Packers Meat and Seafood, Georgia Main and many others.

CANEX Foods has been in operation since 1985 distributing a selection of products to wholesale, retail, foodservice and c-store customers across Canada coast-to-coast. CANEX Foods products reach hundreds of customers and locations daily. Retail clients include almost every major retailer across Canada including Save On Foods, Choices, Sobey's, Loblaws, as well as many independent chains and local butcher shops.

CANEX Foods has placed an initial purchase order of fourteen pallets of NATERA Plant Based Foods to begin servicing their clientele.

CANEX Foods GM Mr. Sean Lewis comments, "Historically, our company has focused solely on meat proteins to supply all segments of the food business. As dietary choices and trends continue to change with the times, we have adapted our product offerings to meet consumer demands for value-added and plant-based proteins. We are pleased and excited to extend this relationship with Naturally Splendid and offer NATERA Plant Based Foods to not only satisfy our client's requests, but to offer the highest quality and best-tasting foods available in the market."

The growing demand for plant-based products isn't so much the result of a widespread shift to vegetarianism, as less than 10 per cent of Canadians are vegetarian or vegan. Rather, it is the result of an increasing number of consumers referred to as flexitarians who want to eat less meat but aren't ready to give it up entirely. Reports have shown that 90 per cent of consumers who tried plant-based meats in the past 12 months fit that description. NATERA Plant Based Foods creates delicious plant-based products that appeals to this rapidly growing consumer category.

Naturally Splendid CEO Mr. J. Craig Goodwin states, "Expanding our working relationship with CANEX Foods benefits Naturally Splendid on many levels including increased logistic efficiencies, cost savings, as well as leveraging business relationships that CANEX has developed over their 35 years of doing business. In particular, the forward-looking strategy displayed by CANEX in extending their product lines to appeal to the flexitarian market is perfectly in line with the strategy at Naturally Splendid and we very much look forward to building on this relationship".

About Naturally Splendid Enterprises Ltd.

Founded in 2010, NSE operates a Safe Quality Food Level 2 certified food manufacturing facility just outside Vancouver, BC in Canada. The Company has established numerous healthy, functional foods under recognized brands such as Natera Sport™, Natera Hemp Foods, CHII, Elevate Me™ and Woods Wild Bar™, and most recently Natera Plant Based Foods, a line of delicious plant-based meat alternatives for the rapidly growing plant-based market segment.

The Company has a myriad of new products and line extensions under development that are approaching launch. NSE, through its joint venture Plasm Pharmaceutical, has been approved for conducting a phase 2 clinical trial approved by Health Canada for treatment of COVID-19.

NSE has also developed proprietary technologies for the extraction of high-demand, healthy omega 3 and 6 oils from hemp.

NSE contract manufacturers for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many healthy food companies, private labeling a wide variety of nutritional food products destined for global healthy food markets.

For more information e-mail or call Investor Relations at 604-465-0548 ext.105

On Behalf of the Board of Directors

Mr. J. Craig Goodwin
CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.
(NSP - TSX Venture; NSPDF - OTCQB; 50N - Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control including, Naturally Splendid's ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.


SOURCE: Naturally Splendid Enterprises Ltd.

View source version on

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
Sirona Biochem (TSXV:SBM)

Sirona Biochem Inc.

Keep reading...Show less
BriaCell Closes $4 Million Strategic Investment by Prevail Partners, LLC at US$8.63 per Share

BriaCell Closes $4 Million Strategic Investment by Prevail Partners, LLC at US$8.63 per Share

briacell therapeutics corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, is pleased to announce that the Company has completed the previously-announced strategic investment by Prevail Partners, LLC (" Prevail Partners ") in the Company (the " Investment "), in accordance with a stock purchase agreement (the " Agreement ") entered into between the Company and Prevail Partners on May 12, 2023. Pursuant to the Agreement, the Company issued 463,408 common shares (the " Shares ") to Prevail Partners (the " Issuance ") at a price per Share of US$8.63 for aggregate gross proceeds of US$4 million.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Boosh Hires Pixie Brands and Multi Brands Sampling Co for BC Promos and Store Sampling

Boosh Hires Pixie Brands and Multi Brands Sampling Co for BC Promos and Store Sampling

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company"), a premier plant-based brand in the "better for you" food sector, announced today it is working with Pixie Brands @meetpixiebrands and Multi Brand Sampling Co @multibrandsmaplingco to promote and enhance sales at store level for all Boosh and Beanfields brands in BC.

Founded by CPG founder April Angelini, Pixie Brands offers a relationship-based, boots on the ground approach to help small and medium brands SHINE. They offer sales and distributor support and organize In-Store Events.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less


Amgen (NASDAQ:AMGN) today issued the following statement in response to the U.S. Federal Trade Commission's (FTC) complaint seeking to block the company's proposed acquisition of Horizon Therapeutics plc:

"Amgen is disappointed by the FTC's decision and remains committed to completing this acquisition, which will bring significant benefits to patients suffering from very serious rare diseases in the U.S. and around the world.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
BriaCell Announces $4 Million Strategic Investment and Clinical Alliance with Prevail Partners, LLC and Prevail InfoWorks, Inc.

BriaCell Announces $4 Million Strategic Investment and Clinical Alliance with Prevail Partners, LLC and Prevail InfoWorks, Inc.

  • Prevail Partners, LLC to purchase 463,408 BriaCell common shares at a price of $8.63 for gross proceeds of $4 million, representing a 20% premium to the trailing thirty (30) trading day VWAP.
  • Prevail InfoWorks, Inc. to act as Contract Research Organization (CRO) for BriaCell's upcoming pivotal study, expected to commence in 2023.

briacell therapeutics corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that the Company has signed a Master Service and Technology Agreement ("MSTA") agreement with Prevail InfoWorks, Inc. ("InfoWorks"), a Philadelphia, PA based Contract Research Organization (CRO), to provide clinical services and technologies for BriaCell's upcoming pivotal study in advanced metastatic breast cancer. Services include clinical site coordination, project management, clinical monitoring and pharmacovigilance (safety management) services, and the use of InfoWork's integrated real-time data analytics platform, The Single Interface ® for clinical support and real-time data analysis.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
  Sirona Biochem Chief Scientific Officer Géraldine Deliencourt-Godefroy

Sirona Biochem Eyes Licensing Deal for Anti-aging Compound After Clinical Trial Results

Sirona Biochem (TSXV:SBM) is looking forward to securing a licensing deal after a clinical trial for its novel anti-aging compound TFC-1326 showed exceptional results, according to Géraldine Deliencourt-Godefroy, the company’s chief scientific officer.

“We have ongoing discussions with different partners that have shown interest in this compound … we have an event in Boston where we (will) share with other prospects (the) best results in order to find a way to license this compound,” Deliencourt-Godefroy said.

The clinical trial was conducted among 20 volunteers who used the compound in cream form two times a day for three months.

Keep reading...Show less

Latest Press Releases

Related News